MA12.08 Preventing Infusion-Related Reactions with Intravenous Amivantamab: Primary Results from SKIPPirr, a Phase 2 Study.
| Autor: | Lopes, G., Spira, A.I., Han, J.-Y., Shih, J.-Y., Mascaux, C., Basu Roy, U., Zugazagoitia, J., Kim, Y.J., Chiu, C.-H., Kim, S.-W., Nadal, E., Gil-Bazo, I., Murphy, S., Mahadevia, P., Anderson, B.G., Xia, K., Wang, G., Bauml, J.M., Chioda, M., Simoes, J. |
|---|---|
| Zdroj: | Journal of Thoracic Oncology; 2024 Supplement, Vol. 19 Issue 10, pS104-S105, 2p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|